Sanctuary Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
Other funds holding ARKG
JFG
Sanctuary Advisors's ARKG Position: Q2 2026 in Review
Sanctuary Advisors increased its ARK Genomic Revolution ETF (ARKG) stake by 0.98% in Q2 2026, buying an estimated $16.6K and bringing the position to 53,624 shares worth $2.26M. The position accounts for 0.01% of the portfolio, ranked #993.
Sanctuary Advisors first reported a position in ARKG in Q2 2024 and has held it in 8 quarters since. 271 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.
- Sanctuary Advisors held 53,624 shares of ARK Genomic Revolution ETF worth $2.26M as of Q2 2026.
- Sanctuary Advisors bought 522 ARK Genomic Revolution ETF shares in Q2 2026, an estimated $16.6K.
- ARK Genomic Revolution ETF made up 0.01% of Sanctuary Advisors's portfolio in Q2 2026, its #993 holding.
- Sanctuary Advisors first reported a position in ARK Genomic Revolution ETF in Q2 2024 and has held it in 8 quarters since.
- 271 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.
Based on Sanctuary Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.